Hemipiperazines as peptide-derived molecular photoswitches with low-nanomolar cytotoxicity.

Molecular photoswitches transform light energy into reversible structural changes. Their combination with known pharmacophores often allows for photomodulation of the biological activity. The effort to apply such compounds in photopharmacology as light-activated pro-drugs is, however, hampered by serious activity reduction upon pharmacophore modifications, or limited biostability.

Fluorinated Azobenzenes Switchable with Red Light.

Molecular photoswitches triggered with red or NIR light are optimal for photomodulation of complex biological systems, including efficient penetration of the human body for therapeutic purposes ("therapeutic window"). Yet, they are rarely reported, and even more rarely functional under aqueous conditions. In this work, fluorinated azobenzenes are shown to exhibit efficient E→Z photoisomerization with red light (PSS >75 % Z) upon conjugation with unsaturated substituents.

Photocontrol of Drug Release from Supramolecular Hydrogels with Green Light.

Photoresponsive smart materials transform light energy into sophisticated functions. They find increasing biomedical applications in light-induced drug-release and photopharmacology, because they can provide the desired therapeutic effect locally due to precise spatiotemporal dosage control. However, the majority of reported studies rely on cytotoxic UV light that penetrates tissues poorly.

Photoresponsive self-healing supramolecular hydrogels for light-induced release of DNA and doxorubicin.

An azobenzene-containing cyclic dipeptide PAP-DKP-Lys is a photoresponsive low-MW hydrogelator. The gelation process can be triggered with temperature, pH, light, and ionic strength. The resulting self-healing gels can encapsulate dsDNA or an anticancer drug doxorubicin, and release them in a light-dependent manner.